awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35608564-2C7F5257-2CB8-48B1-8149-E4DCD5A12642
Q35608564-2C7F5257-2CB8-48B1-8149-E4DCD5A12642
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35608564-2C7F5257-2CB8-48B1-8149-E4DCD5A12642
A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma.
P2860
Q35608564-2C7F5257-2CB8-48B1-8149-E4DCD5A12642
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35608564-2C7F5257-2CB8-48B1-8149-E4DCD5A12642
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8a6966081cbc8f4e53ed2b2b39e6e904559901b
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.